Literature DB >> 12099955

Predictors of insulin sensitivity in Type 2 diabetes mellitus.

E Bonora1, G Targher, M Alberiche, G Formentini, F Calcaterra, S Lombardi, F Marini, M Poli, L Zenari, A Raffaelli, S Perbellini, M B Zenere, F Saggiani, R C Bonadonna, M Muggeo.   

Abstract

AIMS: To identify the independent predictors of insulin sensitivity in Type 2 diabetes, and to establish whether isolated Type 2 diabetes (i.e. diabetes without overweight, dyslipidaemia and hypertension) is a condition of insulin resistance.
METHODS: We examined 45 patients with non-insulin-treated Type 2 diabetes undergoing a 4-h euglycaemic hyperinsulinaemic clamp (20 mU/m2 per min) combined with 3H-3-D-glucose and 14C-U-glucose infusions and indirect calorimetry. We also examined 1366 patients with non-insulin-treated Type 2 diabetes randomly selected among those attending the Diabetes Clinic and in whom insulin resistance was estimated by Homeostasis Model Assessment (HOMA-IR).
RESULTS: In the 45 patients undergoing glucose clamp studies, insulin-mediated total glucose disposal (TGD) was independently and negatively associated with systolic blood pressure (standardized beta coefficient = -0.407, P = 0.003), plasma triglycerides (beta= -0.355, P = 0.007), and HbA1c (beta= -0.350, P = 0.008). The overall variability of TGD explained by these variables was 53%. Overweight diabetic subjects with central fat distribution, hypertension, hypertriglyceridaemia and poor glycometabolic control had insulin-mediated TGD values markedly lower than their lean counterparts without hypertension, with normal triglycerides, and with good glycometabolic control (16 +/- 5 vs. 31 +/- 10 micromol/min per kg lean body mass, P < 0.01). Nevertheless, the latter still were markedly insulin-resistant when compared with sex- and age-matched non-diabetic control subjects (31 +/- 10 vs. 54 +/- 13 micromol/min per kg lean body mass, P < 0.01). In the 1366 Type 2 diabetic patients of the epidemiological study, HOMA-IR value was independently associated with HbA1c (beta = 0.283, P < 0.0001), plasma triglycerides (beta = 0.246, P < 0.0001), body mass index (beta = 0.139, P < 0.001), waist girth (beta = 0.124, P < 0.001) and hypertension (beta = 0.066, P = 0.006).
CONCLUSION: Overweight, central fat distribution, dyslipidaemia, hypertension and poor glycometabolic control are strong independent predictors of insulin resistance in Type 2 diabetes. However, reduced insulin sensitivity can be found even when Type 2 diabetes is isolated and well controlled.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099955     DOI: 10.1046/j.1464-5491.2002.00764.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  11 in total

1.  Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups.

Authors:  Blanca I Restrepo; Léanie Kleynhans; Alejandra B Salinas; Bassent Abdelbary; Happy Tshivhula; Genesis P Aguillón-Durán; Carine Kunsevi-Kilola; Gloria Salinas; Kim Stanley; Stephanus T Malherbe; Elizna Maasdorp; Moncerrato Garcia-Viveros; Ilze Louw; Esperanza M Garcia-Oropesa; Juan Carlos Lopez-Alvarenga; John B Prins; Gerhard Walzl; Larry S Schlesinger; Katharina Ronacher
Journal:  Tuberculosis (Edinb)       Date:  2018-08-18       Impact factor: 3.131

2.  [13C]glucose breath testing provides a noninvasive measure of insulin resistance: calibration analyses against clamp studies.

Authors:  Maysa Hussain; Morteza Jangorbhani; Sally Schuette; Robert V Considine; Robin L Chisholm; Kieren J Mather
Journal:  Diabetes Technol Ther       Date:  2013-10-11       Impact factor: 6.118

3.  The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics.

Authors:  Martha Lappas; Piyushkumar A Mundra; Gerard Wong; Kevin Huynh; Debra Jinks; Harry M Georgiou; Michael Permezel; Peter J Meikle
Journal:  Diabetologia       Date:  2015-04-17       Impact factor: 10.122

Review 4.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

5.  Basal insulin resistance and secretion in Nigerians with type 2 diabetes mellitus.

Authors:  J M Oli; A A Adeyemo; G O Okafor; E N Ofoegbu; B Onyenekwe; C J Chukwuka; C N Onwasigwe; S Ufelle; G Chen; C N Rotimi
Journal:  Metab Syndr Relat Disord       Date:  2009-12       Impact factor: 1.894

6.  Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering.

Authors:  Elizabeth J Mayer-Davis; Bo Ma; Andrew Lawson; Ralph B D'Agostino; Angela D Liese; Ronny A Bell; Dana Dabelea; Lawrence Dolan; David J Pettitt; Beatriz L Rodriguez; Desmond Williams
Journal:  Metab Syndr Relat Disord       Date:  2009-04       Impact factor: 1.894

7.  Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance.

Authors:  N Maneka G De Silva; Rachel M Freathy; Tom M Palmer; Louise A Donnelly; Jian'an Luan; Tom Gaunt; Claudia Langenberg; Michael N Weedon; Beverley Shields; Beatrice A Knight; Kirsten J Ward; Manjinder S Sandhu; Roger M Harbord; Mark I McCarthy; George Davey Smith; Shah Ebrahim; Andrew T Hattersley; Nicholas Wareham; Debbie A Lawlor; Andrew D Morris; Colin N A Palmer; Timothy M Frayling
Journal:  Diabetes       Date:  2011-01-31       Impact factor: 9.461

8.  Differential associations of oral glucose tolerance test-derived measures of insulin sensitivity and pancreatic β-cell function with coronary artery calcification and microalbuminuria in type 2 diabetes.

Authors:  Claire K Mulvey; Ann M McNeill; Cynthia J Girman; Timothy W Churchill; Karen Terembula; Jane F Ferguson; Rachana Shah; Nehal N Mehta; Atif N Qasim; Michael R Rickels; Muredach P Reilly
Journal:  Diabetes Care       Date:  2013-08-15       Impact factor: 19.112

9.  Clinicopathologic assessment of hypogonadism in men with type 2 diabetes mellitus.

Authors:  Theophilus E Ugwu; Rosemary T Ikem; Babatope A Kolawole; Ignatius U Ezeani
Journal:  Indian J Endocrinol Metab       Date:  2016 Sep-Oct

10.  New measure of insulin sensitivity predicts cardiovascular disease better than HOMA estimated insulin resistance.

Authors:  Kavita Venkataraman; Chin Meng Khoo; Melvin K S Leow; Eric Y H Khoo; Anburaj V Isaac; Vitali Zagorodnov; Suresh A Sadananthan; Sendhil S Velan; Yap Seng Chong; Peter Gluckman; Jeannette Lee; Agus Salim; E Shyong Tai; Yung Seng Lee
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.